Featured, News, Trade Ideas

CURRENC Launches SEAMLESS AI Call Centre Solutions to Revolutionize Financial Services

January 8, 2025 No comments yet

CURRENC Group (Nasdaq: CURR), a fintech pioneer focused on serving unbanked and underbanked individuals, has unveiled its SEAMLESS AI Call Centre Solutions, an advanced suite of AI-powered tools aimed at transforming customer service for financial institutions and enterprises globally.

The SEAMLESS AI suite includes three key products:

  • Text AI: Offers real-time, chat-based customer interactions for personalized Q&As and follow-ups.
  • Voice AI: Enables hands-free, conversational user support for tasks ranging from simple inquiries to complex transaction guidance.
  • Avatar AI: Delivers lifelike interactions via 2D or 3D avatars to enhance user engagement and task resolution.

Available in over 10 languages and seamlessly integrated into mobile apps, SEAMLESS AI supports functions like marketing and debt collection, providing 24/7 global service while streamlining operations and reducing costs.

CURRENC also plans to bolster its offerings by developing AI-focused hardware, including an AI Data Centre (AIDC) and AI-as-a-Service infrastructure, to deliver customized solutions for enterprises.

“The launch of SEAMLESS AI marks a milestone in our mission to redefine financial services with AI-driven innovation,” said Alex Kong, Founder and Executive Chairman of CURRENC. “By integrating advanced AI tools, we’re empowering enterprises to deliver cost-effective, high-quality services to underserved populations worldwide.”

Founded in 2013, CURRENC has been at the forefront of fintech and digital remittance, enabling financial inclusion for millions. In 2023, the company processed $4.54 billion in remittance transactions, a 28% increase from 2022, and now serves over one million users across 150 countries. Following its Nasdaq listing in September 2024, CURRENC is set to expand its international presence, deepen its AI investments, and elevate the global financial ecosystem.

You might like this article: Lucid Group Reports Q4 2024 Production and Delivery Totals

Leave a Reply

Your email address will not be published. Required fields are marked *

Continue reading

Featured, News, Trade Ideas

FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity

March 3, 2025 No comments yet

BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration (FDA) has officially closed its inspection of a single site involved in the TRANQUILITY II Phase 3 trial under 21 C.F.R.20.64(d)(3). The FDA’s designation of “Voluntary Action Indicated” (VAI) signals that while minor issues may have been identified, no regulatory action is required, further […]

Featured, News, Trade Ideas

Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine

February 20, 2025 No comments yet

Telomir Pharmaceuticals (NASDAQ: TELO) has achieved a major scientific breakthrough by stabilizing Silver(II) (Ag²⁺) using its proprietary compound, Telomir-1. This advancement overcomes a key challenge in silver-based medicine, unlocking new possibilities for antimicrobial treatments, wound care, and infection-resistant medical coatings. Silver(II) offers superior antibacterial action, faster wound healing, and immune-modulating properties compared to traditional Silver(I) […]

Featured, News, Trade Ideas

flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

February 14, 2025 No comments yet

flyExclusive (NYSE American: FLYX), a leading provider of premium jet charter experiences, has entered into a definitive agreement to acquire the aviation business of Jet.AI (NASDAQ: JTAI). The deal will allow flyExclusive to expand its fleet and market presence while enabling Jet.AI to transition into a pure-play AI solutions company. Under the terms of the […]